Skip to content
10-K

Annual Report

POINT BIOPHARMA GLOBAL INC.

0001811764-23-000007

← back to feed
Filed
Mar 27, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2022 · Mar 22, 2023 105.68M sh
Shares Diluted FY 2022 · Dec 31, 2022 96.03M sh
Shares Diluted FY 2022 · Dec 31, 2021 73.85M sh
Dividends Paid FY 2022 · Dec 31, 2022 $0
Dividends Paid FY 2022 · Dec 31, 2021 $0
Capex FY 2022 · Dec 31, 2022 $12.77M
Capex FY 2022 · Dec 31, 2021 $8.8M
Operating Cash Flow FY 2022 · Dec 31, 2022 $183.52M
Operating Cash Flow FY 2022 · Dec 31, 2021 −$44.7M
Short Term Investments FY 2022 · Dec 31, 2022 $238.78M
Short Term Investments FY 2022 · Dec 31, 2021 $0
Cash And Equivalents FY 2022 · Dec 31, 2022 $286.43M
Cash And Equivalents FY 2022 · Dec 31, 2021 $238.82M
Current Liabilities FY 2022 · Dec 31, 2022 $79.74M
Current Liabilities FY 2022 · Dec 31, 2021 $7.98M
Total Liabilities FY 2022 · Dec 31, 2022 $91.37M
Total Liabilities FY 2022 · Dec 31, 2021 $8.05M
Current Assets FY 2022 · Dec 31, 2022 $530.82M
Current Assets FY 2022 · Dec 31, 2021 $243.85M
Total Assets FY 2022 · Dec 31, 2022 $578.32M
Total Assets FY 2022 · Dec 31, 2021 $263.26M
Eps Diluted FY 2022 · Dec 31, 2022 $1.02
Eps Diluted FY 2022 · Dec 31, 2021 −$0.62
Eps Basic FY 2022 · Dec 31, 2022 $1.04
Eps Basic FY 2022 · Dec 31, 2021 −$0.62
Sga Expense FY 2022 · Dec 31, 2022 $19.01M
Sga Expense FY 2022 · Dec 31, 2021 $12.01M
Rd Expense FY 2022 · Dec 31, 2022 $82.05M
Rd Expense FY 2022 · Dec 31, 2021 $33.51M
Net Income FY 2022 · Dec 31, 2022 $98.29M
Net Income FY 2022 · Dec 31, 2021 −$45.9M
Operating Income FY 2022 · Dec 31, 2022 $125.52M
Operating Income FY 2022 · Dec 31, 2021 −$45.51M
Revenue FY 2022 · Dec 31, 2022 $226.58M
Revenue FY 2022 · Dec 31, 2021 $0